Preclinical study of AV0012 early stage inhibitor of hepatitis C virus infection: I. In vitro ADME and pharmacokinetics

Autor:	Ivashchenko, A. V., Yamanushkin, P. M., Mit Kin, O. D., Ezhova, E. V., Korzinov, O. M., Shevkun, N. A., Koryakova, A. G., Karapetyan, R. N., Bychko, V. V., Ivashchenko, A. A., Agrba, V. Z., Lapin, B. A., Orlov, S. V.
Zdroj:	Scopus-Elsevier
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1b25085c47a2b69a0060d6d8d8371d2e http://www.scopus.com/inward/record.url?eid=2-s2.0-84901404801&partnerID=MN8TOARS Zobrazit plný text záznamu